Quality of life and duration of hemodialysis in patients with chronic kidney disease (CKD): a cross-sectional study

• Main Authors: Jefferson Belarmino Nunes Barbosa, Elaine Cristina Santa Cruz de Moura, Celine Lorena Oliveira Barboza de Lira, Patrícia Érika de Melo Marinho
• Format: Article
• Language: English
• Published: Editora Champagnat
• Series: Fisioterapia em Movimento
• Subjects: Insuficiência Renal Crônica; Diálise Renal; Qualidade de vida
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-51502017000400781&lng=en&tlng=en

Abstract Introduction: Quality of life (QoL) of hemodialysis patients is a major evaluative marker currently measured, while treatment time is a clinical determinant associated with impaired QOL. Objective: To evaluate QOL in individuals undergoing hemodialysis (HD) considering treatment time and the presence of comorbidities. Methods: A cross-sectional study conducted in the hemodialysis unit of the Hospital das Clínicas da Universidade Federal de Pernambuco (HC-UFPE). We studied patients with Chronic Kidney Disease (CKD) of both genders over the age of 18 years, at any level of education and undergoing HD for at least 6 months. We evaluated the demographic/socioeconomic and clinical data, followed by application of the quality of life questionnaire (KDQOL-SF). Results: Participants were 47 patients with a mean age of 50.94 ± 13.33 years, 55.3% were male and average treatment time of 57.35 ± 61.46 months. Hypertension (59.6%) was the most frequent underlying disease. According to the responses obtained through the KDQOL-SF, the situation at work and physical limitation scored worse. Sexual function (85.83) and encouragement by the team had the best performance. There were no differences in dimensions of questionnaire and treatment time. Conclusion: The presence of comorbidities and HD duration were not found to be possible factors for changing QoL in this study. However, we suggest that future studies evaluate other factors such as laboratory, emotional and functional data to check for changes in QoL in these patients related to HD duration.